Rege Nephro Co Ltd
Rege Nephro Co., Ltd. is a South Korean company specializing in the development of regenerative treatments for kidney diseases. The company is advancing clinical trials for RN-014, a promising treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD), and preparing for U.S. clinical trials. Additionally, Rege Nephro is completing preclinical trials for RN-032, a cell therapy product targeting Chronic Kidney Disease (CKD).
Leadership & Board
- Current Number of Employees
- 16
- Current LinkedIn Followers
- 347
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $15M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $15M
- Latest Funding Round
- Series B
- Post-Money Valuation
- ―
Company Momentum Positive
Rege Nephro Co Ltd LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Rege Nephro Co Ltd had 16 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Rege Nephro Co Ltd had 347 followers as of October 12, 2026. The number of followers increased by 1 (0.29%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Series B | $15.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| DCI Partners Co., Ltd. | Series B |
| JIC Venture Growth Investments Co., Ltd. | Series B |
| Nippon Venture Capital CO., Ltd. | Series B |
| TOHOKU University Venture Partners Co., Ltd. | Series B |
| Golden Asia Fund Ventures Ltd. | Series B |
| Mitsui Chemicals, Inc. | Series B |
| Global Brain Corporation | Series B |
| Kyoto University Innovation Capital Co., Ltd. | Series B |
Similar Companies
A snapshot of private companies similar to Rege Nephro Co Ltd, helping you discover and navigate related company profiles.
Related News and Analysis
